Larvol Delta - BioPath-Holdings-Announces-Successful-Completion-of-Higher-Dose-Second-Cohort-in-Phase-11b-Clinical-Trial-of-BP1002-in-RefractoryRelapsed-Acute-Myeloid-Leukemia-AML-Patients

BP1002 - Bio-Path

https://www.globenewswire.com/news-release/2024/04/18/2865259/0/en/Bio-Path-Holdings-Announces-Successful-Completion-of-Higher-Dose-Second-Cohort-in-Phase-1-1b-Clinical-Trial-of-BP1002-in-Refractory-Relapsed-Acute-Myeloid-Leukemia-AML-Patients.html

Apr 18, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next